- Home
- RIGL vs SHYF Comparison
RIGL vs SHYF Comparison
Compare RIGL & SHYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- SHYF
- Stock Information
- Founded
- RIGL 1996
- SHYF 1975
- Country
- RIGL United States
- SHYF United States
- Employees
- RIGL N/A
- SHYF N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- SHYF Auto Manufacturing
- Sector
- RIGL Health Care
- SHYF Consumer Discretionary
- Exchange
- RIGL Nasdaq
- SHYF Nasdaq
- Market Cap
- RIGL 486.4M
- SHYF 411.2M
- IPO Year
- RIGL 2000
- SHYF N/A
- Fundamental
- Price
- RIGL $21.81
- SHYF $12.59
- Analyst Decision
- RIGL Buy
- SHYF Strong Buy
- Analyst Count
- RIGL 5
- SHYF 2
- Target Price
- RIGL $34.80
- SHYF $15.50
- AVG Volume (30 Days)
- RIGL 347.9K
- SHYF 273.9K
- Earning Date
- RIGL 03-04-2025
- SHYF 02-20-2025
- Dividend Yield
- RIGL N/A
- SHYF 1.61%
- EPS Growth
- RIGL N/A
- SHYF N/A
- EPS
- RIGL 0.22
- SHYF N/A
- Revenue
- RIGL $157,374,000.00
- SHYF $787,077,000.00
- Revenue This Year
- RIGL $51.34
- SHYF N/A
- Revenue Next Year
- RIGL $15.75
- SHYF $9.38
- P/E Ratio
- RIGL $98.50
- SHYF N/A
- Revenue Growth
- RIGL 21.65
- SHYF N/A
- 52 Week Low
- RIGL $7.48
- SHYF $9.81
- 52 Week High
- RIGL $29.82
- SHYF $17.56
- Technical
- Relative Strength Index (RSI)
- RIGL 64.53
- SHYF 56.60
- Support Level
- RIGL $17.28
- SHYF $11.68
- Resistance Level
- RIGL $18.25
- SHYF $12.76
- Average True Range (ATR)
- RIGL 1.37
- SHYF 0.55
- MACD
- RIGL 0.65
- SHYF 0.23
- Stochastic Oscillator
- RIGL 99.68
- SHYF 93.51
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About SHYF The Shyft Group Inc.
The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.